DOD-CDMRP: Prostate Cancer Research Program - Health Disparity Research Award

Studies proposed for this award mechanism are expected to improve the understanding  of, and ultimately eliminate, PC health disparities. Applicants for this award must explicitly state how the proposed  research is related to an area of PC health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to health care, insurance status, age, geography, and cultural  beliefs. Funding $450K over 3 years. Funding for the Qualified Collaborator Option: $600K over 3 years.

All applications for PCRP funding opportunities should also address at least one of 6 PCRP focus areas:
 - Biomarkers: Discovery and validation of biomarkers for the detection, prediction of response to therapy, prognosis,  and progression of PC.
 - Genetics: Understanding the genetics and epigenetics responsible for susceptibility, disease progression, and  treatment outcomes for clinically significant PC.
 - Imaging: Development of new anatomic and molecular imaging technology for the detection and management of PC.
 - Survivorship: Studies on the impact of treatment, nutrition, metabolism, and exercise on the well-being of PC patients and their families.
 - Therapy: Identification of new targets, pathways, and therapeutic modalities, including immunotherapy and mechanisms of resistance.
 - Tumor Biology and Immunology: Understanding prognosis and progression of PC.

Each PCRP funding opportunity either requires or encourages applications to address one of the following PCRPoverarching challenges:
- Develop effective treatments for advanced PC (i.e. disease relapse with no available curative therapy);
- Distinguish aggressive from indolent disease.